Omnicell (OMCL) Reports In-Line Q4
More News related to OMCL
- Omnicell Introduces Anywhere RN for Remote Medication Management to Improve Clinician Efficiency in Hospitals
- Omnicell Introduces Anywhere RN for Remote Medication Management to Improve Clinician Efficiency in Hospitals
- Omnicell to Present at Piper Jaffray Healthcare Conference
- Omnicell (OMCL) Reports In-Line Q4
- Omnicell Announces Third Quarter 2009 Results
More News related to Earnings
- Analyst Sees Google (GOOG) Headed Higher
- RBC Lifts Price Target on Best Buy (BBY) to $49
- Broadpoint.AmTech Lowers Est and Price Target on Research In Motion (RIMM), But Sticks With Buy Rating
- Deere (DE) Shares Rising as Analysts Getting Bullish
- Soleil Calls Fertilizer Stocks 'Over-Valued', Recommends Taking Profits (POT, MOS, IPI)
Omnicell (Nasdaq: OMCL) reports Q3 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter was $54 million, which compares to the estimate of $52.7 million.
Related Categories
EarningsStocks Mentioned
-0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
